The mRNA from the K-ras protooncogene is alternatively spliced into 2 trans
cripts, K-ras4A and K-ras4B, which possess 2 alternative fourth coding exon
s. In the present study, expression of K-ras4A and K-ras4B transcripts in 8
organs, including heart, brain, spleen, lung, liver, skeletal muscle kidne
y, and testis, from BALB/c mice were determined by Northern blot hybridizat
ion. k-ras4B, observed in all organs, accounted for approximately 90% to 99
% of total K-ras mRNA. K-ras4A. was detected only in lung, liver, and kidne
y. In addition, K-ras expression in lungs and K-ras4A/K-ras4B ratios in lun
g, liver, spleen and kidney from A/J, BALB/c, C3H/HeJ, and C57BL/6J mice we
re determined. A/J lungs expressed K-ras mRNA 2-fold higher than C3H/HeJ or
C57BL/6J lungs, whereas K-ras mRNA expression in BALB/c lungs was intermed
iate Higher percentages of K-ras4A mRNA were found in lungs and kidneys fro
m A/J and BALB/c mice, as compared with those from C3H/HeJ and C57BL/6J mic
e. Levels of K-ras4A and K-ras4B mRNAs were also examined in 20 NIH 3T3 cel
l lines transformed by DNA from spontaneous A/J mouse lung tumors. K-ras4A
was expressed 2- to 3-fold higher in these cell lines than in nontransforme
d NIH 3T3 cells and in CIO cell lines. These results suggest that: (1) ther
e may be functional differences between the protein encoded by K-ras4A and
that encoded by K-ras4B in each tissue type, and in tumor cells; and (2) K-
ras mRNA expression and K-ras4A/K-ras4B ratios detected in lung tissues fro
m different strains of mice correlate with susceptibility to tumor inductio
n.